€940,00
The Genomind Professional PGx Test is a clinically validated pharmacogenetic test developed and performed in a CLIA- and CAP-certified laboratory in the United States.
It is intended to provide healthcare professionals with genetic information that may assist in medication selection and dosing for individuals with mental health and neurological conditions.
The test evaluates genetic variants involved in drug metabolism, transport, and pharmacodynamic response.
These insights help clinicians assess potential gene-drug and drug-drug-gene interactions.
Looks at genetic differences that may affect how your body responds to medications, providing insight into individual variability in treatment response.
Focuses on enzymes influenced by genetics that may play a role in how medications are processed and broken down in the body.
Examines how genes and enzymes may interact within medication pathways, helping clinicians understand potential interactions and variability.
Have questions about The Genomind Professional PGx Test?
We’ve compiled answers to the most common questions to help healthcare professionals better understand how pharmacogenetic testing can support informed medication selection and dosing in mental health and neurological care.
Yes. As part of the process, DAWA GENETICS will send your information first to a licensed provider who will review, authorize and order the test. (In certain circumstances, a provider may deem a patient ineligible to take the test.)
All of the below are included:
Genomind Professional PGx Test analyzes 26 genes and provides guidance across a wide variety of conditions and diagnoses.
Genomind Professional PGx Test evaluates over 150 drugs representing over 99% of the most commonly prescribed medications.
During registration (and before payment), users have the option to provide current / potential medications.
No. This test is designed to provide information about:
Tests provided by DAWA GENETICS LABORATORY (including Genomind Professional PGX test) don’t make any prescribing decisions.
For changes to medications, users must see their existing prescribing provider.
Timing depends on several factors, including how quickly a provider can review the information and authorize your test, the shipping times to and from your home, the time it takes you to complete the cheek swab, the current workload of the lab.
Most often, the process takes between 2-4 weeks.
– Medication categories
with genetic guidance
– Color-coded risk indicators
– Clinical interpretation notes
Following report delivery, DAWA GENETICS Laboratory offers complimentary expert consultations for clinicians. These consultations are performed by experienced psychopharmacologists or clinical pharmacists to support accurate interpretation of test results.
Our site uses cookies. By clicking on accept you agree with our privacy policy.
